LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,551,320 | -2.7% | 38,000 | 0.0% | 0.86% | +7.5% |
| Q2 2023 | $2,623,140 | +43.0% | 38,000 | 0.0% | 0.80% | +56.1% |
| Q1 2023 | $1,833,880 | -3.2% | 38,000 | 0.0% | 0.51% | -12.5% |
| Q4 2022 | $1,894,300 | +22.1% | 38,000 | 0.0% | 0.58% | +17.7% |
| Q3 2022 | $1,551,000 | -65.5% | 38,000 | +15222.6% | 0.50% | +957.4% |
| Q2 2022 | $4,500,000 | -20.1% | 248 | -94.5% | 0.05% | -96.3% |
| Q1 2022 | $5,632,000 | +2594.7% | 4,500 | 0.0% | 1.27% | +2602.1% |
| Q4 2021 | $209,000 | -91.6% | 4,500 | -90.9% | 0.05% | -92.2% |
| Q3 2021 | $2,497,000 | – | 49,500 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |